<DOC>
	<DOCNO>NCT01780844</DOCNO>
	<brief_summary>The purpose study evaluate efficacy safety ASKP1240 , anti-CD40 monoclonal antibody , prophylaxis organ rejection kidney transplantation . This study compare efficacy basiliximab induction , ASKP1240 , mycophenolate mofetil ( MMF ) , steroid [ calcineurin inhibitor ( CNI ) avoidance ] standard care immunosuppressive regimen ( basiliximab induction + tacrolimus + MMF + steroid ) . In addition , study compare efficacy basiliximab induction , ASKP1240 , tacrolimus steroid [ CNI minimization-MMF avoidance ] standard care immunosuppressive regimen ( basiliximab induction + tacrolimus + MMF + steroid ) .</brief_summary>
	<brief_title>A Study Assess Efficacy Safety ASKP1240 de Novo Kidney Transplant Recipients</brief_title>
	<detailed_description>Subjects follow 6 month . Upon completion first 6 month study , subject may participate Long Term Extension period study . Subjects remain original treatment arm three year post-transplant ( / Sponsor discontinues development subject longer wish participate study ) .</detailed_description>
	<mesh_term>Prednisone</mesh_term>
	<mesh_term>Mycophenolic Acid</mesh_term>
	<mesh_term>Tacrolimus</mesh_term>
	<mesh_term>Basiliximab</mesh_term>
	<mesh_term>Mycophenolate mofetil</mesh_term>
	<criteria>Subject recipient de novo kidney living decease donor Subject induction therapy , studyassigned basiliximab , plan part initial immunosuppressive regimen Subject previously receive receive organ transplant kidney Subject receive solitary kidney decease donor &lt; 5 year age Subject receive kidney anticipate cold ischemia time ( CIT ) &gt; 30 hour Subject receive kidney meet Extended Criteria Donor ( ECD ) Donation Cardiac Death ( DCD ) criterion . Note : kidney meet either ECD DCD criterion eligible inclusion Subject receive ABO incompatible donor kidney Subject current calculate panel reactive antibody ( cPRA ) level &gt; 50 %</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>January 2017</verification_date>
	<keyword>Kidney Transplantation</keyword>
	<keyword>de novo Kidney Transplantation</keyword>
	<keyword>ASKP1240</keyword>
</DOC>